Arca
Skip to content

Cobas Integra Creatinine Plus VER.2 Assay

Enzymatic Method, Creatinine. 510(k) K024098, from Roche Diagnostics Corp. (Indianapolis, IN). Product code JFY, class 2.

As of Nov 16, 2026, K024098 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Dec 19, 2002 after 7 days, with 2 recalls tied to it in FDA's recall database.

  • Substantially equivalent: Dec 19, 2002
  • Review time: 7 days
  • Recalls: 2
  • Cited as a predicate by: 6 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The cassette COBAS INTEGRA Creatinine plus ver.2 (CREP2) contains an in vitro diagnostic reagent system intended for use on COBAS INTEGRA systems for the quantitative determination of the creatinine concentration in serum, plasma, and urine.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

6 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K024098, newest first; each opens FDA's recall record
Dec 14, 2018Z-1125-2019COBAS INTEGRA 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-overTerminated
Jun 11, 2008Z-0008-2009Some of the labels are glossy, resulting in the bar code being difficult to read by the bar code reader.Terminated

Other JFY Clearances

The newest 510(k)s for the same product code; their median review was 185 days; see every JFY device

Record

Type
Special
Received
Dec 12, 2002
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1225

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.